ECO Animal Health Email Format
Pharmaceutical ManufacturingEngland, United Kingdom51-200 Employees
ECO Animal Health is a UK-based pharmaceutical company that develops and markets branded veterinary medicines for global animal health. The firm focuses on antibiotics and vaccines for pigs and poultry, led by Aivlosin, a proprietary medication that targets both respiratory and intestinal diseases. It operates from the United Kingdom with global offices supporting research, development and manufacturing, and it holds marketing authorisations in more than 70 countries. Its customers include veterinary professionals and animal producers worldwide who rely on medicines and vaccines to manage disease in swine and poultry operations. In 2024 ECO announced investments to strengthen its research and development pipeline, prioritising late-stage poultry vaccines and vaccines for swine. The same year, the company appointed Joachim Hasenmaier as a non-executive director.